Details for New Drug Application (NDA): 019909
✉ Email this page to a colleague
NDA 019909 describes ZOVIRAX, which is a drug marketed by Pharmobedient, Bausch, and Glaxosmithkline, and is included in six NDAs. It is available from three suppliers. Additional details are available on the ZOVIRAX profile page.
The generic ingredient in ZOVIRAX is acyclovir sodium. There are fifty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
The generic ingredient in ZOVIRAX is acyclovir sodium. There are fifty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 019909
| Tradename: | ZOVIRAX |
| Applicant: | Pharmobedient |
| Ingredient: | acyclovir |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019909
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 22, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
